Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options
Authors
Keywords
-
Journal
Cells
Volume 10, Issue 5, Pages 1049
Publisher
MDPI AG
Online
2021-04-29
DOI
10.3390/cells10051049
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Switching to aflibercept versus continuing bevacizumab for treatment‐resistant neovascular age‐related macular degeneration: a one‐year comparative observational study
- (2021) Yngvil Solheim Husum et al. ACTA OPHTHALMOLOGICA
- Switching to intravitreal fluocinolone acetonide implant for refractory diabetic macular edema: 12- and 24-month results
- (2021) Argyrios Chronopoulos et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Prostaglandin E2 promotes pathological retinal neovascularisation via EP4R-EGFR-Gab1-AKT signaling pathway
- (2021) Tianhua Xie et al. EXPERIMENTAL EYE RESEARCH
- Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema
- (2021) Hidetaka Noma et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Aflibercept plus micropulse laser versus aflibercept monotherapy for diabetic macular edema: 1-year results of a randomized clinical trial
- (2020) Mahmoud Alaa Abouhussein et al. INTERNATIONAL OPHTHALMOLOGY
- Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
- (2020) Yolla Haibe et al. Frontiers in Oncology
- Prospective PED-study of intravitreal aflibercept for refractory vascularized pigment epithelium detachment due to age-related macular degeneration: morphologic characteristics of non-responders in optical coherence tomography
- (2020) C. R. Clemens et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration
- (2020) Liza-Marie Marquis et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration
- (2020) Jayashree Sahni et al. JAMA Ophthalmology
- Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration
- (2020) Arshad M. Khanani et al. JAMA Ophthalmology
- Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
- (2020) Tock H. Lim et al. JAMA Ophthalmology
- Combination of apolipoprotein-A-I/apolipoprotein-A-I binding protein and anti-VEGF treatment overcomes anti-VEGF resistance in choroidal neovascularization in mice
- (2020) Lingping Zhu et al. Communications Biology
- Long‐term results of rescue photodynamic therapy for type 1 neovascularization refractory to anti‐vascular endothelial growth factor
- (2020) Un Chul Park et al. ACTA OPHTHALMOLOGICA
- Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
- (2019) Min Zhao et al. Nature Communications
- Association of Intravitreal Anti–Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration
- (2019) Lauren A. Dalvin et al. JAMA Ophthalmology
- Effect of Ranibizumab and Aflibercept on Best-Corrected Visual Acuity in Treat-and-Extend for Neovascular Age-Related Macular Degeneration
- (2019) Mark C. Gillies et al. JAMA Ophthalmology
- Long-term outcomes of switching to aflibercept for treatment-resistant neovascular age-related macular degeneration
- (2019) Kimberly Spooner et al. ACTA OPHTHALMOLOGICA
- The Placental Growth Factor Pathway and Its Potential Role in Macular Degenerative Disease
- (2019) Fiona Cunningham et al. CURRENT EYE RESEARCH
- Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study
- (2019) lias Georgalas et al. Cutaneous and Ocular Toxicology
- The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
- (2019) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Interferon Alpha-2b Eye Drops Prevent Recurrence of Pterygium After the Bare Sclera Technique
- (2019) Mingyang Yin et al. CORNEA
- Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results
- (2019) Catharina Busch et al. ACTA DIABETOLOGICA
- Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study
- (2019) Richard P Gale et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Aflibercept and navigated versus conventional laser in diabetic macular oedema: a 12‐month randomized clinical trial
- (2019) Søren L. Blindbæk et al. ACTA OPHTHALMOLOGICA
- Clinical Characteristics of Polypoidal Choroidal Vasculopathy and Anti-Vascular Endothelial Growth Factor Treatment Response in Caucasians
- (2019) Gregg T. Kokame et al. OPHTHALMOLOGICA
- Subthreshold micropulse laser reduces anti-VEGF injection burden in patients with diabetic macular edema
- (2018) Elad Moisseiev et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- A novel and less invasive technique to assess cytokine profile of vitreous in patients of diabetic macular oedema
- (2018) G Srividya et al. EYE
- Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway
- (2018) Yoshiro Itatani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features
- (2018) Katja Hatz et al. OPHTHALMOLOGICA
- HIGH-DOSE HIGH-FREQUENCY AFLIBERCEPT FOR RECALCITRANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2018) Qi Sheng You et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- VISUAL ACUITY IMPROVEMENT WHEN SWITCHING FROM RANIBIZUMAB TO AFLIBERCEPT IS NOT SUSTAINED
- (2018) Cecilia S. Lee et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema
- (2018) Raj K. Maturi et al. JAMA Ophthalmology
- Evaluation of the effect of combined intravitreal ranibizumab injection and sub-tenon steroid injection in the treatment of resistant diabetic macular edema
- (2018) Erdem Eriş et al. INTERNATIONAL OPHTHALMOLOGY
- Ranibizumab versus aflibercept for the treatment of vascularized pigment epithelium detachment due to age-related macular degeneration
- (2018) Alexandros Rouvas et al. INTERNATIONAL OPHTHALMOLOGY
- Early Response to Anti–Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol T
- (2018) Neil M. Bressler et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Bevacizumab dosing every 2 weeks for neovascular age-related macular degeneration refractory to monthly dosing
- (2018) Michael Mimouni et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti–Vascular Endothelial Growth Factor
- (2018) Anthony Obeid et al. OPHTHALMOLOGY
- EFFICACY OF ADJUVANT TOPICAL DORZOLAMIDE–TIMOLOL IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION REFRACTORY TO ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
- (2018) Ji Hwan Lee et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Intravitreal Dexamethasone in Patients with Wet Age-Related Macular Degeneration Resistant to Anti-VEGF: A Prospective Pilot Study
- (2018) Ermete Giancipoli et al. Journal of Ophthalmology
- Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy
- (2018) Jeffrey G. Gross et al. JAMA Ophthalmology
- Prostaglandin E2/EP2 receptor signalling pathway promotes diabetic retinopathy in a rat model of diabetes
- (2018) Man Wang et al. DIABETOLOGIA
- Treatment of refractory diabetic macular edema with a fluocinolone acetonide implant in vitrectomized and non-vitrectomized eyes
- (2018) International Journal of Ophthalmology
- Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes with Macular Edema Secondary to Central or Hemiretinal Vein Occlusion
- (2018) Michael S. Ip et al. JAMA Ophthalmology
- Aflibercept in diabetic macular edema refractory to previous bevacizumab: outcomes and predictors of success
- (2017) Rita Laiginhas et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Resultate nach Rückumstellung von intravitrealem Aflibercept auf Ranibizumab bei persistierender Aktivität einer altersbedingten Makuladegeneration
- (2017) Sören Waibel et al. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
- Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial
- (2017) Sobha Sivaprasad et al. LANCET
- Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema
- (2017) Bernardete Pessoa et al. OPHTHALMIC RESEARCH
- INTRAVITREAL DEXAMETHASONE IMPLANT AS ADJUVANT TREATMENT FOR BEVACIZUMAB- AND RANIBIZUMAB-RESISTANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2017) Anita Barikian et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- OUTCOME OF INTRAVITREAL AFLIBERCEPT FOR REFRACTORY PIGMENT EPITHELIAL DETACHMENT WITH OR WITHOUT SUBRETINAL FLUID AND SECONDARY TO AGE-RELATED MACULAR DEGENERATION
- (2017) Kiyoung Kim et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Efficacy of the Intravitreal Sustained-Release Dexamethasone Implant for Diabetic Macular Edema Refractory to Anti-Vascular Endothelial Growth Factor Therapy: Meta-Analysis and Clinical Implications
- (2017) Zainab Khan et al. Ophthalmic Surgery Lasers & Imaging Retina
- Combinatorial treatment with topical NSAIDs and anti-VEGF for age-related macular degeneration, a meta-analysis
- (2017) Songshan Li et al. PLoS One
- Efficacy of carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa: A meta-analysis
- (2017) Qinzhu Huang et al. PLoS One
- Long-Term Results of Pro Re Nata Regimen of Aflibercept Treatment in Persistent Neovascular Age-Related Macular Degeneration
- (2016) Ilkay Kilic Muftuoglu et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Early and Long-Term Responses to Anti–Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data
- (2016) Victor H. Gonzalez et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Morphological and functional changes in recalcitrant diabetic macular oedema after intravitreal dexamethasone implant
- (2016) Pierluigi Iacono et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Effect of aflibercept on refractory macular edema associated with central retinal vein occlusion
- (2016) Michael N. Cohen et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- Receiver Operating Characteristic Curve to Predict Anti-VEGF Resistance in Retinal Vein Occlusions and Efficacy of Ozurdex
- (2016) Jeremy D. Wolfe et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Bromfenac Eyedrops in the Treatment of Diabetic Macular Edema: A Pilot Study
- (2016) Antonio Pinna et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- One-Year Results of Aflibercept in Vascularized Pigment Epithelium Detachment due to Neovascular AMD: A Prospective Study
- (2016) Daniele Veritti et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Efficacy of vitrectomy and inner limiting membrane peeling in age-related macular degeneration resistant to anti-vascular endothelial growth factor therapy, with vitreomacular traction or epiretinal membrane
- (2016) Shuhei Kimura et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Intravitreal injection of methotrexate in persistent diabetic macular edema: a 6-month follow-up study
- (2016) Khalil Ghasemi Falavarjani et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- High-frequency aflibercept injections in persistent neovascular age-related macular degeneration
- (2016) Ilkay Kilic Muftuoglu et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Angiogenesis and Inflammation Crosstalk in Diabetic Retinopathy
- (2016) Margarida Capitão et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
- (2016) John A. Wells et al. OPHTHALMOLOGY
- PIGMENT EPITHELIAL DETACHMENT RESPONSE TO AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION REFRACTORY TO RANIBIZUMAB
- (2016) Sophie de Massougnes et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- PDGF-CC underlies resistance to VEGF-A inhibition and combinatorial targeting of both suppresses pathological angiogenesis more efficiently
- (2016) Lei Zheng et al. Oncotarget
- A Meta-Analysis of Studies Evaluating Visual and Anatomical Outcomes in Patients with Treatment Resistant Neovascular Age-Related Macular Degeneration following Switching to Treatment with Aflibercept
- (2016) Sophie Seguin-Greenstein et al. Journal of Ophthalmology
- Intravitreal Diclofenac plus Bevacizumab versus Bevacizumab alone in treatment-naive diabetic macular edema: a randomized double-blind clinical trial
- (2016) Heshmatollah Ghanbari et al. INTERNATIONAL OPHTHALMOLOGY
- One-Year Outcomes of Aflibercept in Recurrent or Persistent Neovascular Age-Related Macular Degeneration
- (2015) Cheryl A. Arcinue et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment
- (2015) Yüksel Totan et al. CURRENT EYE RESEARCH
- Defining response to anti-VEGF therapies in neovascular AMD
- (2015) W M Amoaku et al. EYE
- The Effect of Switching Ranibizumab to Aflibercept in Refractory Cases of Macular Edema Secondary to Ischemic Central Vein Occlusion
- (2015) L. Lehmann-Clarke et al. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
- The REVEAL Study
- (2015) Tatsuro Ishibashi et al. OPHTHALMOLOGY
- THREE-YEAR RESULTS OF POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH PHOTODYNAMIC THERAPY
- (2015) Chee Wai Wong et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment
- (2015) Andre J. Witkin et al. Seminars in Ophthalmology
- One-Year Results From Clinical Practice of Epimacular Strontium-90 Brachytherapy for the Treatment of Subfoveal Choroidal Neovascularization Secondary to AMD
- (2015) Dinah Zur et al. Ophthalmic Surgery Lasers & Imaging Retina
- Quantification of Change in Pigment Epithelial Detachment Volume and Morphology After Transition to Intravitreal Aflibercept in Eyes With Recalcitrant Neovascular AMD: 18-Month Results
- (2015) Aditya Kanesa-Thasan et al. Ophthalmic Surgery Lasers & Imaging Retina
- Efficacy of Ozurdex implant in recalcitrant diabetic macular edema—a single-center experience
- (2015) Pooja Bansal et al. INTERNATIONAL OPHTHALMOLOGY
- Polypoidal Choroidal Vasculopathy in Asians
- (2015) Chee Wong et al. Journal of Clinical Medicine
- Short-term efficacy of intravitreal triamcinolone acetonide for bevacizumab-resistant diabetic macular oedema
- (2014) Jae Hui Kim et al. ACTA OPHTHALMOLOGICA
- Comparison of Exudative Age-related Macular Degeneration Subtypes in Japanese and French Patients: Multicenter Diagnosis With Multimodal Imaging
- (2014) Gabriel Coscas et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial)
- (2014) Charles C Wykoff et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Visual and anatomical outcomes following intravitreal aflibercept in eyes with recalcitrant neovascular age-related macular degeneration: 12-month results
- (2014) D S Grewal et al. EYE
- Dexamethasone Intravitreal Implant in Vitrectomized Versus Nonvitrectomized Eyes for Treatment of Patients with Persistent Diabetic Macular Edema
- (2014) Marco Dutra Medeiros et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- EFFECT OF INTRAVITREAL TRIAMCINOLONE IN DIABETIC MACULAR EDEMA UNRESPONSIVE TO INTRAVITREAL BEVACIZUMAB
- (2014) Sohee Jeon et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- RESPONSE TO AFLIBERCEPT AS SECONDARY THERAPY IN PATIENTS WITH PERSISTENT RETINAL EDEMA DUE TO CENTRAL RETINAL VEIN OCCLUSION INITIALLY TREATED WITH BEVACIZUMAB OR RANIBIZUMAB
- (2014) James A. Eadie et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Intravitreal diclofenac versus intravitreal bevacizumab in naive diabetic macular edema: a randomized double-masked clinical trial
- (2014) Masoud Soheilian et al. INTERNATIONAL OPHTHALMOLOGY
- Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab
- (2013) Hyung Cho et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Polypoidal Choroidal Vasculopathy Exudation and Hemorrhage: Results of Monthly Ranibizumab Therapy at One Year
- (2013) Gregg T. Kokame et al. OPHTHALMOLOGICA
- Combination Therapy for Neovascular Age-related Macular Degeneration Refractory to Anti-Vascular Endothelial Growth Factor Agents
- (2013) Kevin Tozer et al. OPHTHALMOLOGY
- Emerging Therapies for Neovascular Age-Related Macular Degeneration
- (2013) Peter K. Kaiser OPHTHALMOLOGY
- Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration
- (2013) Brandon G. Busbee et al. OPHTHALMOLOGY
- MYOCARDIAL INFARCTION AFTER INTRAVITREAL VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS
- (2013) Anna Kemp et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- TREATMENT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR–RESISTANT DIABETIC MACULAR EDEMA WITH DEXAMETHASONE INTRAVITREAL IMPLANT
- (2013) Ratimir Lazic et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Effect of Prostaglandin E2 on Vascular Endothelial Growth Factor Production in Nasal Polyp Fibroblasts
- (2013) Dong Yeol Han et al. Allergy Asthma & Immunology Research
- Association of Inflammatory Factors With Macular Edema in Branch Retinal Vein Occlusion
- (2013) Hidetaka Noma et al. JAMA Ophthalmology
- SAVE (Super-dose Anti-VEGF) Trial: 2.0 mg Ranibizumab for Recalcitrant Neovascular Age-Related Macular Degeneration: 1-Year Results
- (2013) Charles C. Wykoff et al. Ophthalmic Surgery Lasers & Imaging Retina
- Vitreomacular traction in a case of exudative age-related macular degeneration resistant to anti-VEGF therapy
- (2012) Sanket U. Shah et al. ACTA OPHTHALMOLOGICA
- Pilot study to evaLuate the role of high-dose rAnibizumab 2.0 mg in the management of neovascular age-related macular degeneration in patients with perSistent/recurrenT macular fluid
- (2012) A T Fung et al. EYE
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Super-dose Anti-VEGF (SAVE) Trial: 2.0 mg Intravitreal Ranibizumab for Recalcitrant Neovascular Macular Degeneration–Primary End Point
- (2012) David M. Brown et al. OPHTHALMOLOGY
- Vascular Endothelial Growth Factor A in Intraocular Vascular Disease
- (2012) Joan W. Miller et al. OPHTHALMOLOGY
- EVEREST STUDY
- (2012) Adrian Koh et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- The RESTORE Study
- (2011) Paul Mitchell et al. OPHTHALMOLOGY
- PHARMACOKINETIC RATIONALE FOR DOSING EVERY 2 WEEKS VERSUS 4 WEEKS WITH INTRAVITREAL RANIBIZUMAB, BEVACIZUMAB, AND AFLIBERCEPT (VASCULAR ENDOTHELIAL GROWTH FACTOR TRAP-EYE)
- (2011) Michael W. Stewart et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease
- (2011) Michael Tolentino SURVEY OF OPHTHALMOLOGY
- Efficacy of Sustained Topical Dorzolamide Therapy for Cystic Macular Lesions in Patients With Retinitis Pigmentosa and Usher Syndrome
- (2010) Mohamed A. Genead ARCHIVES OF OPHTHALMOLOGY
- Regression of Peripapillary Choroidal Neovascularization after Oscillatory Transpupillary Thermotherapy and Anti-VEGF Pharmacotherapy
- (2010) Gholam Peyman et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Intravitreal Bevacizumab Combined With Intravitreal Triamcinolone for Therapy-Resistant Exudative Age-Related Macular Degeneration
- (2010) Yong Tao et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic Implications
- (2010) Claudio Campa et al. MEDIATORS OF INFLAMMATION
- Ranibizumab for Macular Edema following Central Retinal Vein Occlusion
- (2010) David M. Brown et al. OPHTHALMOLOGY
- One-Year Results of Reduced-Fluence Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
- (2009) Ayana Yamashita et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Standard Care to Treat Vision Loss Associated With Macular Edema Secondary to Branch Retinal Vein Occlusion
- (2009) ARCHIVES OF OPHTHALMOLOGY
- A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion
- (2009) ARCHIVES OF OPHTHALMOLOGY
- Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study
- (2009) A. Galor et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Effect of Bevacizumab on Inflammation and Proliferation in Human Choroidal Neovascularization
- (2008) Olcay Tatar ARCHIVES OF OPHTHALMOLOGY
- Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience
- (2008) S. Frenkel et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Vascular endothelial growth factor in eye disease
- (2008) J.S. Penn et al. PROGRESS IN RETINAL AND EYE RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started